| Identification | Back Directory | [Name]
Benzamide, 3-[[(2R)-4-methyl-2-morpholinyl]methoxy]-5-(5-methyl-2-thiazolyl)-N-[(1R)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]- | [CAS]
1948232-63-0 | [Synonyms]
Filapixant
Benzamide, 3-[[(2R)-4-methyl-2-morpholinyl]methoxy]-5-(5-methyl-2-thiazolyl)-N-[(1R)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]- | [Molecular Formula]
C24H26F3N5O3S | [MOL File]
1948232-63-0.mol | [Molecular Weight]
521.56 |
| Chemical Properties | Back Directory | [density ]
1.302±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 146.67 mg/mL (281.21 mM; Need ultrasonic) | [form ]
Solid | [pka]
12.99±0.46(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
Filapixant is a purinoreceptor antagonist extracted from patent WO2016091776A1, example 348. Filapixant is the active reference substance of Eliapixant[1]. | [References]
[1] Davenport AJ, et, al. 1,3-thiazol-2-yl substituted benzamides. WO2016091776A1. |
|
|